The Safety and Efficacy of Second-line Single Docetaxel (75 mg/m2) Therapy in Advanced Non-Small Cell Lung Cancer Patients who were Previously Treated With Platinum-based Chemotherapy

참고문헌 (25)

1. "Chemotherapy in non-small cell lung cancer a meta-analysis using updated data on individual patients from 52 randomized clinical trials", 311, pp.899~909 (1995)
2. "Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer", 15, pp.2996~3018 (1997)
3. "Management strategies for recurrent non-small cell lung cancer", 24, pp.455~62 (1997)
4. "Single agents in the second-line treatment of nonsmall cell lung cancer", 25, pp.10~4 (1998)
5. "Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group", 18, pp.2354~62 (2000)
6. "Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy", 18, pp.2095~103 (2000)
7. "American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline:update 2003", 22, pp.330~53 (2004)
8. "Reporting results of cancer treatment", 47, pp.207~14 (1981)
9. "Gemcitabine as second-line treatment for advanced non-small-cell lung cancer:a phase II trial", 17, pp.2081~5 (1999)
10. "A phase II study testing paclitaxel as secondline single agent treatment for patients with advanced nonsmallcell lung cancer failing after a first-line chemotherapy", 37, pp.73~7 (2002)
11. "Failure of vinorelbine to produce responses in pretreated non-small cell lung cancer patients", 14, pp.1413~5 (1994)
12. "Gemcitabine and vinorelbine as second-line therapy in non-small-cell lung cancer after prior treatment with taxane+platinum-based regimens", 37, pp.972~8 (2001)
13. "Pilot study of vinorelbine (navelbine) and paclitaxel in patients with refractory non-small cell lung cancer.", 23, pp.19~21 (1996)
14. "Salvage treatment with paclitaxel and gemcitabine for patients with non-small-cell lung cancer after cisplatin- or docetaxel-based chemotherapy:a multicenter phase II study", 9, pp.1127~30 (1998)
15. "A phase II trial of docetaxel and ifosfamide for patients with platinum-resistant or refractory non-small cell lung cancer in a salvage setting", 36, pp.287~92 (2004)
16. "Activity of docetaxel in platinum-treated non-small cell lung cancer:results of a phase II multicenter trial", 18, pp.131~5 (2000)
17. "Docetaxel and granulocyte colony-stimulating factor in patients with advanced non-small cell lung cancer previously treated with platinum-based chemotherapy:a multicenter phase II trial", 43, pp.257~62 (1999)
18. "Phase II study of docetaxel for advanced or metastatic platinum-refractory non-small-cell lung cancer", 13, pp.645~51 (1995)
19. "Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial.", 290, pp.2149~58 (2003)
20. "Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advancednon-small-cell lung cancer (The IDEAL 1 Trial).", 21, pp.2237~46 (2003)
21. "ISEL:A phase III survival study comparing gefitinib (IRESSA) plus best supportive care (BSC) with placebo plus BSC in patients with advanced non-small cell lung cancer who had received one or two prior chemotherapy regimens.", 49, pp.54~ (2005)
22. "Gefitinib as a first-line therapy of advanced or metastatic adenocarcinoma of the lung in never-smokers", 11, pp.3032~7 (2005)
23. "ALIMTA? (pemetrexed disodium) as second-line treatment of non-small cell lung cancer: A phase II study", 21, pp.2636~44 (2003)
24. "Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy", 22, pp.1589~97 (2004)
25. "Retrospective analysis of safety and efficacy of low-dose docetaxel 60 mg", m2 in advanced non-small cell lung cancer patients previously treated with platinum-based chemotherapy, 2003, pp.26, 459~64

관련 논문AI추천